Kane Biotech Inc. (KNE:CA) Shareholder/Analyst Call Prepared Remarks Transcript#Kane #Biotech #KNECA #ShareholderAnalyst #Call #Prepared #Remarks #Transcript
Tag: biotech
Biotech stock sends Wall Street surprising signal
Kardigan (KARD) didn’t just raise $400 million. The heart-drug developer sent a new signal to biotech…
U.S. IPO Weekly Recap: Another Biotech IPO Pops During The Short Holiday Week
U.S. IPO Weekly Recap: Another Biotech IPO Pops During The Short Holiday Week#U.S #IPO #Weekly #Recap…
Wall Street sees huge upside as Novo Nordisk backs biotech company
Veru (VERU) stock has not been easy to own. The little biotech has spent years persuading…
Exclusive: Apoha, startup pioneering AI based on liquid ‘wave form’ data, gets $36 million Series A
Apoha, a deep tech startup that is building AI models for creating new kinds of substances—from…
California sues 23andMe over alleged ‘lax’ data security that failed to protect users’ data
California’s attorney general sued the genetic testing company formerly known as 23andMe on Thursday, alleging it…
From Seed to Sale: What VC's Want in Biotech Startups
Dr. Andrew Snyder (Monash University) joins the show to discuss the current biotech landscape: rising M&A…
Exploring structural changes in healthcare and biotech
You can also listen to this podcast on iono.fm here. SIMON BROWN: I’m chatting now with…